BioLife Solutions
BLFS
165 hedge funds and large institutions have $690M invested in BioLife Solutions in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 57 increasing their positions, 53 reducing their positions, and 23 closing their positions.
1,324% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $74K
8% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 53
0.89% less ownership
Funds ownership: 90.14% → 89.25% (-0.89%)
5% less funds holding
Funds holding: 174 → 165 (-9)
21% less capital invested
Capital invested by funds: $874M → $690M (-$184M)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$19.6M |
| 2 |
Jennison Associates
New York
|
+$8.05M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.37M |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$2.21M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$12.5M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$8.82M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
-$7.85M |
| 4 |
FAM
Fred Alger Management
New York
|
-$3.83M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.57M |
BLFS Hedge Fund Activity: Q4 2022 in Review
165 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2022, worth a combined $690M — down 21% from $874M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BLFS and 15 opened new positions — a net loss of 8 holders — while 53 trimmed existing stakes and 57 added.
The largest buyer was Park West Asset Management, opening a new position worth an estimated $19.6M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $12.5M sold.
- 165 institutional investors held BioLife Solutions (BLFS) as of Q4 2022, down from 174 in Q3 2022.
- Funds reported $690M of BioLife Solutions stock for Q4 2022, down 21% quarter-over-quarter.
- 15 funds opened new BioLife Solutions positions in Q4 2022 and 23 closed out, a net change of -8 holders.
- The largest BioLife Solutions buyer in Q4 2022 was Park West Asset Management, an estimated $19.6M added.
- The largest BioLife Solutions seller in Q4 2022 was TimesSquare Capital Management, an estimated $12.5M sold.
Based on aggregated 13F filings for Q4 2022.